OptimizeRx Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPRX research report →
Companywww.optimizerx.com
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.
- CEO
- Stephen L. Silvestro
- IPO
- 2007
- Employees
- 128
- HQ
- Waltham, MI, US
Price Chart
Valuation
- Market Cap
- $93.26M
- P/E
- 13.64
- P/S
- 0.87
- P/B
- 0.72
- EV/EBITDA
- 5.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 69.05%
- Op Margin
- 13.57%
- Net Margin
- 6.37%
- ROE
- 5.47%
- ROIC
- 6.53%
Growth & Income
- Revenue
- $109.43M · 18.78%
- Net Income
- $5.13M · 125.52%
- EPS
- $0.28 · 125.45%
- Op Income
- $12.06M
- FCF YoY
- 290.56%
Performance & Tape
- 52W High
- $22.25
- 52W Low
- $4.57
- 50D MA
- $6.36
- 200D MA
- $12.68
- Beta
- 1.19
- Avg Volume
- 540.02K
Get TickerSpark's AI analysis on OPRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Greco Theresa | other | 914 |
| May 15, 26 | Greco Theresa | other | 879 |
| May 15, 26 | Silvestro Stephen L | other | 5,219 |
| Apr 3, 26 | Presti Mariyamma Varghese | other | 0 |
| Feb 11, 26 | Odence-Ford Marion | other | 4,000 |
| Feb 11, 26 | Odence-Ford Marion | other | 1,386 |
| Feb 11, 26 | Odence-Ford Marion | other | 4,000 |
| Dec 23, 25 | Greco Theresa | other | 1,420 |
| Dec 23, 25 | Silvestro Stephen L | other | 3,361 |
| Dec 23, 25 | Odence-Ford Marion | other | 4,051 |
Our OPRX Coverage
We haven't published any research on OPRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OPRX Report →